Management of relapsed ovarian cancer in routine clinical practice: a case study.
CONCLUSION: Second-line use of trabectedin + PLD in patients with limited platinum sensitivity may restore sensitivity at next platinum.
PMID: 30223695 [PubMed - in process]
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Ovarian Cancer | Ovaries | Study | Toxicology